💊 Amazon’s virtual clinic takes off; Boomtime for biosimilars; GSK’s new TB treatment
#217 | Care for some bone marrow in a dish?
Hello and welcome back to The Kable. It has been a relatively slow news week thus far, and it feels like everybody is just waiting for something. Like Immunogen, who has been waiting 41 years for a solo drug approval, finally scored a nod from the US FDA for its ovarian cancer drug this week.
Amazon's push into healthcare continues to gather steam. In its latest offering, the e-commerce major has launched a virtual clinic for more than 20 common health conditions.
In the UK, people nostalgic for the days of WWII are rejoicing after supermarkets started rationing eggs being sold to customers. Thank you, bird flu.
And finally, many days after announcing a truce, aid is at last making its way to Ethiopia's Tigray region.